Certara Appoints Eran Broshy as New Independent Board Member
13 juil. 2022 08h00 HE
|
Certara
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective...
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
12 juil. 2022 08h00 HE
|
Certara
PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of...
Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development
28 juin 2022 08h00 HE
|
Certara
PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for...
Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
21 juin 2022 08h00 HE
|
Certara
PRINCETON, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Certara Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of new versions of its Immunogenicity (IG),...
Certara Reports First Quarter 2022 Financial Results
05 mai 2022 16h15 HE
|
Certara
PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2022. ...
Certara to Participate in Upcoming Investor Conferences
03 mai 2022 16h30 HE
|
Certara
PRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
20 avr. 2022 08h00 HE
|
Certara
PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of...
Certara Reports Fourth Quarter and Full Year 2021 Financial Results
01 mars 2022 16h15 HE
|
Certara
PRINCETON, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter and full year of 2021...
U.S. FDA Licenses Certara’s Immunogenicity Simulator
23 févr. 2022 16h30 HE
|
Certara
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has licensed...
在过去8年中，美国FDA每一年批准的新药中90%来自Certara的客户
22 févr. 2022 01h26 HE
|
Certara USA, Inc.
新泽西州普林斯顿 , Feb. 22, 2022 (GLOBE NEWSWIRE) -- 全球生物模拟领域的领军企业Certara, Inc.（纳斯达克股票代码：CERT），今日宣布在2021年美国食品药品监督管理局 (FDA) 药品审评和研究中心 (CDER)...